Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cryopak Adds Cold Chain Management Expert To Advisory Board.


Business Editors

VANCOUVER, British Columbia--(BUSINESS WIRE)--Sept. 9, 2002

John Morgan, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Cryopak Industries Inc. (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 BB:CYPKF) (CDNX CDNX

See Canadian Venture Exchange (CDNX).
:CII CII Confederation of Indian Industry
CII Chartered Insurance Institute (UK)
CII Construction Industry Institute (University of Texas)
CII Council of Institutional Investors
) today announced the appointment of Linda Walker, a leading industry expert on cold chain management, to its Advisory Board.

Ms. Walker has over 20 years of experience in the pharmaceutical packaging industry with a specialty in temperature controlled shipping. She began her career with Lederle Laboratories as a Package Engineer. From 1983 to 2002 Ms. Walker was Manager, Package Testing for Wyeth Pharmaceuticals. During this time she was responsible for the design, testing and execution of all phases of package testing, with expertise in thermal package design.

Ms. Walker is a Fellow of Packaging with The American Society for Testing and Materials (ASTM ASTM
abbr.
American Society for Testing and Materials
). She is a frequent speaker at industry seminars on cold chain management issues. Most recently, she was the keynote speaker at the Pharmaceutical Logistics Forum in Belgium, and an article on cold chain management she authored was published in American Pharmaceutical Outsourcing.[M1] Her contributions have been recognized with several industry awards including the ASTM Award of Merit.

In making the announcement, Morgan commented, "We are very pleased to have Linda join Dr. David Winterman and Dr. William Hitchings on our Advisory Board. Our goal is to be the leading innovator in the temperature control industry. Each of these Advisors provides us extensive industry-specific knowledge and expertise that will assist us in our new product and new technology development plans."

About Cryopak:

Cryopak Industries Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:CYPKF) (TSX TSX Toronto Stock Exchange (TSE before April, 2002)
TSX Transfer from Stack Pointer to Index
TSX True Space Extension
 Venture:CII) develops, manufactures and markets quality temperature-controlling products such as the premium patented Cryopak Flexible Ice(TM) Blanket, flexible hot and cold compresses, gel packs, and instant hot and cold packs. The products are used during transport to ensure critical temperature maintenance for pharmaceuticals, blood, airline food and beverages, seafood and all other perishable items. Cryopak's products are also used for first aid, medical and physiotherapy treatments, and, through retail distribution, for daily all-purpose chilling applications.

With almost 10 years of experience in research and development, we also offer expert testing and consulting services to help companies optimize their cold-chain management programs. For more information about Cryopak Industries Inc. or its products, visit www.cryopak.com.

The TSX Venture Exchange TSX Venture Exchange

Originally called the Canadian Venture Exchange (CDNX), this was a result of the merger of the Vancouver and Alberta stock exchanges. The goal of TSX Venture Exchange is to provide venture companies with effective access to capital while protecting investors.
 has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 9, 2002
Words:392
Previous Article:Peer-Reviewed Journal Reports Favorable Outcome On Use of OrCel on Venous Ulcers.
Next Article:ESP Pharma Significantly Expands Its Global Marketing Reach Through a Strategic Alliance with Korean-Based CJ Corporation, Pharmaceutical Division.



Related Articles
Cryopak Receives Opening Retail Orders for Flexible Ice Blanket From Food Store Giant Winn-Dixie.
Distinguished Pharmaceutical Technology Expert Joins Cryopak Advisory Board.
Packaging and Logistics Expert Joins Cryopak Advisory Board - Background Includes 20 years at FedEx.
Cryopak and Novartis Partner to Optimize Cold-Chain Management.
Cryopak Announces Senior Management Appointments.
Cryopak Anticipates Annual Revenue Growth Will Continue To Exceed 50%; AGM Held, Board Approved.
Cryopak Reports 2003 Second Quarter Results: Record Revenues and Earnings.
Cryopak Announces a Major Sales and Brand Building Initiative with Rubbermaid; Deal Expands Penetration for Cryopak into Lucrative U.S. Retail Market.
Getting expert help. (editor's letter).

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles